Evaluating technical feasibility of cGMP production of bioengineered heart tissue to treat heart failure in congenital heart disease

Read full text
Authors: Therapeutic Innovation Australia
Cited by: 0

Fields of Study & Subjects

Tissue Engineering and Regenerative Medicine Congenital heart defects research Pluripotent Stem Cells Research

Publication details

Journal / source
Therapeutic Innovation Australia
Publication date
17 February 2026
Language
EN